Sentences with phrase «source of embryonic stem cells»

However welcome the recent announcement that a team of scientists based at Newcastle University, has grown a section of human liver using stem cells from umbilical cords, rather than from the more controversial source of embryonic stem cells, and whatever the eventual promise or potential of harvesting organs for transplantation from genetically modified pigs, the benefits of either of these two pioneering techniques to currently dying / suffering patients, remain both elusive and distant.

Attempts have been made to bridge this divide by proposing alternative sources of embryonic stem cells for research and therapeutic purposes.

Not exact matches

According to the National Institutes of Health's definition, however, pluripotent embryonic stem cells are «the embryonic source of all cells of the body.»

The NIH defines totipotent cells as the source of both embryonic stem cells and of trophoblast cells which give rise to extra-embryonic tissues such as the placenta.

But on the same day, he also revoked the very kind of policy that promoted the «purple» governance he claimed to want, e.g., Bush's directive that funding priority be given to funding non embryonic — and hence, societally uniting sources of pluripotent stem cells — even though they had already been discovered in the induced pluripotent stem cell breakthrough.

It made the front page of the New York Times, but don't let that dissuade you ¯ reports today about new ethical sources of embryonic - type stem cells are credible, and they are very good news.

Not that a principled moral objection shouldn't be enough, but, for those sitting on the fence, the additional discoveries of alternative sources of embryonic - type stem cells should be decisive.

Stem cells from breast milk can grow into many other kinds of human tissue, raising hopes of an ethical source of embryonic - like stem cStem cells from breast milk can grow into many other kinds of human tissue, raising hopes of an ethical source of embryonic - like stem cstem cells

«We can work with any embryonic stem cell line from any source and are not restricted to working with the very small number of federally approved lines as is the case for researchers in the United States,» says Minger.

But embryonic clones, the source of an endless supply of stem cells imprinted with one's personal DNA, could alter the equation in favor of the patient and augur a paradigm shift in medicine on par with the changes brought about by antibiotics and vaccines.

Scientists have created red blood cells from human embryonic stem cells, in a step that they say could mean an infinite source of blood for transfusions.

After hearing a brief explanation that laid out the different sources of stem cells (but left undiscussed their current uses or future potential for therapy), the respondents offered a slightly more nuanced set of views, and only a slight majority (52 %) supported embryonic stem cell research.

Derivation of pluripotent stem cells, either of embryonic origin or following genetic reprogramming, has opened the path for an alternative source for epidermal cell therapy as these cells are both immortal and pluripotent, theoretically capable of providing any requested number of cells of any desired phenotype.

Human Embryonic Stem (hES) cells derived from Preimplantation Genetic Diagnosed (PGD)- embryos offer a new alternative source of cellular model as they can be largely expanded, differentiated in several cell types and harbors «naturally» the causative mutation of the pathology.

For the first time, through the use of human embryonic stem cells (hES) sourced from pre-implantation diagnosis, researchers from Inserm's Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I - Stem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystrostem cells (hES) sourced from pre-implantation diagnosis, researchers from Inserm's Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I - Stem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystroStem Cell Therapy and Exploration of Monogenic Diseases (I - Stem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystroStem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystrophy.

Embryonic stem cells (ESCs) represent a source for the large numbers of modified EPCs required to therapeutically inhibit tumorigenesis [3], although patient - specific induced pluripotent stem cells (iPSCs) represent a more attractive option.

The aorta - gonad - mesonephros (AGM) region in the aortic wall appears to be the most important source of new blood cells, and it has been found to contain numerous hematopoietic stem cells by day 11 of mouse embryonic development.

LifeMap Discovery ® is a compendium of embryonic development for stem cell research and regenerative medicine, constructed by integrating extensive molecular, cellular, anatomical and medical data curated from scientific literature and high - throughput data sources.

We are the home of the UK Stem Cell Bank which provides a world - leading resource of ethically - sourced, quality - controlled human embryonic and other stem cell lines for research applicatiStem Cell Bank which provides a world - leading resource of ethically - sourced, quality - controlled human embryonic and other stem cell lines for research applicatiCell Bank which provides a world - leading resource of ethically - sourced, quality - controlled human embryonic and other stem cell lines for research applicatistem cell lines for research applicaticell lines for research applications.

The backgrounder below provides summary main points and sources on the position of current NIH Director Dr. Francis Collins in support of human embryonic stem cell research, human cloning, and the creation of ethically - questionable human - animal chimeras.

But, by then, human embryonic stem cells had lost some of their controversial edge, because scientists really had developed an alternative source of cells that reduced the need for material from human embryos.

«This discovery will advance our understanding of stem cell epigenetics and chromatin structures, provide potential mechanisms on maintaining the hallmark properties of ES cells, and help researchers with the rich source of information to better understand some of the unique features — such as self - renewal and pluripotency — of human embryonic stem cells,» said Ng Huck Hui, Ph.D., senior group leader at GIS and a member of the Singapore team that conducted this research.

Until then, however, «although there is excitement that iPS cells can serve as an embryo - free source of stem cells,» says Lanza, «it would be premature to abandon research using embryonic stem cells until we fully understand what's causing these problems.»

The excitement surrounding cellular reprogramming and the possibility of federal funding for human embryonic stem cell (ESC) research in the US could be overshadowing another promising therapeutic source of stem cells: those derived via parthenogenesis, some researchers say.

The discovery, by scientists at Kyoto University and the University of Wisconsin - Madison, seemed to promise a way out of the bitter debates over embryonic - stem - cell research: rather than using human embryos as a source of stem cells, produce them from adult cells.

In September 2010, The New York Times reported that the U.S. Court of Appeals ruled that federal funding of embryonic stem cell research could continue under the new rules while the court considers Judge Lamberth's ruling [source: New York Times].

Alternatively, embryonic stem (ES) cells have emerged as a potential source of less immunogenic hematopoietic progenitor cells (HPCs).

Using cloning technology to derive embryonic stem cells genetically identical to a patient is potentially very important, not only to provide a source of cells that may be used to cure patients, but also to allow for genetic disease to be studied and potential drug treatments to be explored in the laboratory.

Human embryonic stem cells (hESCs) could serve as an expandable source for neurons production, which could be applied for the treatment of various diseases affecting brain.